The class of chemicals identified as BTEB2 activators encompasses a range of compounds known for their roles in modulating signaling pathways and transcriptional regulation. These activators do not directly interact with BTEB2 but are thought to modulate the cellular and molecular context in a way that could enhance BTEB2's activity. One primary mechanism through which these compounds may activate BTEB2 involves the modulation of cellular signaling pathways and metabolic processes. Compounds like Forskolin, EGCG, and Resveratrol are known for their roles in enhancing cellular signaling pathways that can indirectly lead to the activation of transcription factors such as BTEB2. Forskolin's ability to increase cAMP levels, for instance, can influence a variety of signaling pathways, impacting BTEB2's role in gene expression. Similarly, retinoids like Retinoic acid and vitamin D3, through their respective receptors, activate BTEB2 by influencing genes and pathways that interact with or regulate BTEB2.
Another aspect of BTEB2 activation by these compounds is their role in influencing epigenetic regulation and metabolic pathways. Agents like S-Adenosylmethionine, which is involved in methylation processes, and PPARγ agonists like Pioglitazone, known for modulating lipid metabolism and insulin sensitivity, can indirectly activate BTEB2 by affecting the transcriptional landscape. Additionally, compounds like Metformin and Omega-3 fatty acids, which influence cellular energy metabolism and inflammatory responses, respectively, can have indirect effects on BTEB2 activity. The effectiveness of these compounds in activating BTEB2 depends on various factors, including the specific cellular context, the concentration, and duration of exposure, and the presence of other interacting molecules. While these compounds provide valuable insights into the regulation of BTEB2 activity, their role in specifically modulating BTEB2-mediated processes warrants further experimental investigation in relevant biological models.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels. Elevated cAMP can modulate various signaling pathways, potentially leading to the activation of BTEB2 by influencing its expression or activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a polyphenol in green tea, modulates multiple signaling pathways. It can activate BTEB2 activity by altering the cellular signaling environment, potentially affecting pathways that interact with or regulate BTEB2. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid regulates gene expression through retinoic acid receptors. It can potentially activate BTEB2 by influencing genes and pathways that interact with or regulate BTEB2. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol, via its active metabolite, modulates gene expression through the vitamin D receptor. This can lead to the activation of BTEB2 by influencing related genes and signaling pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a PPARγ agonist, modulates lipid metabolism and insulin sensitivity. It can activate BTEB2 indirectly by influencing gene expression pathways associated with BTEB2 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium affects several signaling pathways, including Wnt/β-catenin. Through this modulation, it could activate BTEB2 indirectly by influencing pathways that regulate transcription factors. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
Ademetionine, involved in methylation processes, can influence gene expression. It might activate BTEB2 by altering the methylation status of genes that regulate or are regulated by BTEB2. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin, used for diabetes management, influences AMPK signaling. This can lead to indirect activation of BTEB2 by affecting cellular energy status and related signaling pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol affects various signaling pathways, including those related to cell survival and inflammation. It can activate BTEB2 indirectly by modulating pathways that control its activity or expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane, known for its effects on gene expression and signaling pathways, might activate BTEB2 by altering cellular signaling pathways and transcriptional responses involved in BTEB2 regulation. | ||||||